Figure 3.
Schematic depicting the proportion of subjects eligible for statin therapy per the 2004 ATP III Guidelines, the 2013 ACC/AHA Guidelines, the 2013 ACC/AHA Guidelines using a 5.0% threshold, and the 2011 European Prevention Guidelines across strata of the presence and extent of coronary atherosclerosis as detected by CCTA in 189 patients without prior statin use presenting with acute chest pain in whom an acute coronary syndrome was excluded.